Answers are grounded in this paper and cite their sources.
This experiment shows zofenopril improves oxidative status and stabilizes intraocular pressure in glaucoma models, suggesting therapeutic benefits.
Prolonged systemic administration of zofenopril in a rabbit model of glaucoma effectively attenuated oxidative stress and stabilized intraocular pressure. Zofenopril prevented a progressive rise in IOP observed in untreated animals, maintaining IOP values close to physiological levels throughout the experiment. The treatment resulted in a marked decrease in LPO and MDA accumulation within the retina, optic nerve, and drainage zone, along with reduced generation of hydroxyl and superoxide radicals and a significant restoration of antioxidant enzyme activity.
No takes yet. Share an insight, caveat, or question.
Mikheytseva et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: